Johns Hopkins Surgeon Tapped for "Doctor of the Year" Award

Johns Hopkins Medicine
Office of Corporate Communications
Media contact:  Trent Stockton
410-955-8665; [email protected]
April 25, 2005


Gregory B. Bulkley, M.D., the Mark M. Ravitch Professor of Surgery and director of surgical research at Johns Hopkins, received the annual “Doctor’s Award” from the Myasthenia Gravis Foundation of America in recognition of his “dedicated support to myasthenics through decades of extensive patient education, and the active pursuit of the most effective thymectomy procedure available.” 

Bulkley, a widely renowned surgeon and researcher, will retire May 1 after more than three decades at Johns Hopkins.  He is perhaps best known for his original description of how reactive oxygen species, or “free radicals,” cause tissue injury following loss of blood flow.  His medical reports on the treatment and research of myasthenia gravis and thymoma, or cancer of the thymus gland, are considered to define the standards for the modern surgical treatment of these two conditions.

Myasthenia gravis is a chronic autoimmune neuromuscular disease characterized by fatigue and muscle weakness during activity. Thymectomy, or removal of the thymus gland, is an effective symptomatic treatment for many myasthenia gravis patients.

Bulkley received the award at a special banquet at the Myathenia Gravis Foundation of America’s annual meeting at the Amway Grand Plaza Hotel in Grand Rapids, Mich., on Saturday, April 23, 2005.

On the Web: